The FDA has expanded the approval of Rhapsido (remibrutinib) to include symptomatic dermographism in adults inadequately controlled by H1 antihistamines, backed by phase 3 RemIND trial data.

The use of vibration anesthesia in patients undergoing cryotherapy was associated with pain reductions when compared with cryotherapy alone.

The only baseline characteristic that predicted super response to topical ruxolitinib in patients with nonsegmental vitiligo was disease activity.

New York Governor Kathy Hochul has declared a statewide emergency as measles spreads through rural parts of the state.

Autonomous artificial intelligence in urgent skin cancer pathways can increase clinical capacity for dermatologists.

More frozen organic berries are being recalled because they could be contaminated with a dangerous strain of E coli bacteria.

Dermatology Advisor, a trusted source of medical news and feature content for healthcare providers, offers clinicians insight into the latest research to inform clinical practice and improve patient ...